Rosiglitazone (BRL 49653) enhances insulin secretory response via phosphatidylinositol 3-kinase pathway. [electronic resource]

By: Contributor(s): Producer: 20011207Description: 2598-602 p. digitalISSN:
  • 0012-1797
Subject(s): Online resources: In: Diabetes vol. 50
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.